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Abstract The purpose of this prospective study was to
investigate the association between the severity of coronary
atherosclerosis in angiography and the risk of stroke in
symptomatic coronary artery disease (CAD) patients
without atrial fibrillation or atrial flutter. Associations
between stroke and coronary artery disease were examined
in 1,183 subjects without a history of stroke and who were
referred for diagnostic coronary angiography. Association
between stoke and coronary artery disease was determined
using the COX proportional hazard regression model.
During the follow-up period (mean 6.7 years), 50 strokes
occurred. In the group with strokes there was a higher
prevalence of multi-vessel coronary artery disease (62 vs.
46 %, p \ 0.01). In the COX proportional hazard regres-
sion model, multi-vessel CAD was significantly associated
with the stroke hazard ratio (HR) of 1.8 (CI 1.03–3.43),
determined from a 7-year period of observation. Symp-
tomatic patients with multi-vessel CAD are thus at a high
risk of stroke development.
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Introduction
Recently, an association between strokes and risk of coro-
nary artery disease (CAD) has been reported [1–3]. How-
ever, these studies were performed among patients with
symptoms of acute ischemic stroke or transient ischemic
attack, and CAD was confirmed on the basis of computed
tomography (CT). The gold standard for assessment of
coronary artery stenosis is still conventional coronary
angiography, which has a higher sensitivity and specificity
for detecting coronary lesions [4]. Apart from atheroscle-
rosis, the major causes of ischemic stroke are supraven-
tricular arrhythmias such as atrial fibrillation or atrial flutter.
The risk of ischemic stroke in patients with arrhythmias has
been well established. But so far, the association between
the severity of CAD assessed by angiography and the
prevalence of non-arrhythmic-dependent stroke in symp-
tomatic CAD patients has not been investigated. Thus, the
present prospective study evaluated the relationship
between the severity of coronary atherosclerosis in angi-
ography and the risk of stroke in symptomatic CAD patients
without atrial fibrillation or atrial flutter.
Methods
The study recruited 1,183 consecutive individuals (between
August 2003 and August 2006) based on clinical data or
the findings of an abnormal stress test, who were referred
for diagnostic coronary angiography. The exclusion criteria
were previous stroke or transient ischemic attack, atrial
fibrillation or atrial flutter [patients with paroxysmal atrial
fibrillation were excluded on the basis of the history of this
arrhythmia or any evidence in ECG (ECG at rest or Holter
ECG), history of any supraventricular and ventricular
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arrhythmia lasted C 48 h] and other chronic diseases
leading to limited life expectancy. The study protocol was
approved by the Ethics Committee of the Medical Uni-
versity of Gdansk.
On admission day, before coronary angiography, fasting
blood samples were collected in order to measure total
cholesterol, HDL cholesterol, LDL cholesterol, and tri-
glycerides levels.
According to the findings of the coronary angiography,
significant CAD was considered present when there was
C70 % coronary artery stenosis (CAS) of at least one
coronary artery. The subjects were divided into subgroups:
those without CAS, those with single-vessel CAD (one
CAS C 70 %) and those with multi-vessel CAD (at least
two CAS C 70 %).
Office blood pressure measurement was performed
(OMRON 705 IT) and 24-h ambulatory BP monitoring was
obtained (SpaceLabs 90210) with BP readings set at
20-min intervals (06:00 AM–06:00 PM) and at 30-min
intervals (06:00 PM–06:00 AM).
The subjects were followed from the dates of coronary
angiography until December 31, 2011. The follow-up was
performed during clinic visits, except for patients who were
not able to visit the clinic; in this case the follow-up was
performed by phone . Data about stroke diagnosis was
verified by review of discharge cards, and if the hospital
discharge cards were not available it was verified by
information from the National Polish Health Service.
Stroke diagnosis was performed by neurologists according
to European Stroke Organization guidelines [5]. All sub-
jects were hospitalized in neurologic units, in which stroke
was confirmed via computed tomography, but only 21
patients (42 %) underwent magnetic resonance imaging
(MRI). The ultrasonography of extracranial arteries was
additionally performed in 32 subjects (64 %).
The primary outcomes were all causes of death and were
analyzed as ‘‘survival free of stroke’’. Stroke-free survival
was estimated using the Kaplan–Meier curve at 7 years.
The Kaplan–Meier analysis was performed after excluding
patients who died as a result of the initial stroke. Death
related to initial stroke was defined as death within
1 month of stroke onset. Data from the groups of subjects
were compared using the Student t test for unpaired
observations and the v2 test of proportions. Average dif-
ferences in the groups of CAD were compared by analysis
of variance (ANOVA) with post hoc Tukey HSD test. The
relative hazard (HR) and 95 % CI were estimated for
multi-vessel CAD using COX proportional hazard regres-
sion, adjusted for sex, age, HDL cholesterol, use of med-
ications (acetylsalicylic acid, lipid-lowering drugs [statins
and/or fibrates], angiotensin converting enzyme inhibitors
and others (angiotensin receptor blockers, b-blockers,
diuretics and calcium channel blockers) and 24-h systolic
BP. Throughout the text, the symbol ± refers to the SD of
the mean and p \ 0.05 was taken as the level of statistical
significance.
Results
During the follow-up period (mean 6.7 years), 50 stroke
events occurred in the studied group (7 hemorrhagic and 43
ischemic). According to TOAST classification (Trial of
Org 10172 in Acute Stroke Treatment), 18 (42 %) patients
had ischemic stroke due to small-vessel occlusion, 10
(23 %) patients had ischemic stroke due to large-vessel
atherosclerosis and 15 (35 %) patients had ischemic stroke
due to undetermined etiology. None of the patients had
ischemic stroke due to cardioembolism or due to nonath-
erosclerotic vasculopathies or other determined etiology.
Among 32 subjects who underwent ultrasonography of
extracranial arteries, only 10 (20 %) had C60 % stenosis of
extracranial arteries. The mean period from inclusion up to
stroke was 3.7 years. Within five years of observation, 32
(64 %) strokes occurred. In the 7-year follow-up period,
228 (19 %) patients had coronary angioplasty but none of
them were associated with stroke complications (for all
patients the period between coronary interventions and
stroke was over 30 days).
Table 1 shows baseline characteristics of the cohort
group. In patients with developed stroke, CAD with sig-
nificant CAS was revealed more often with a higher
prevalence of multi-vessel CAD in comparison to patients
without stroke in the follow-up period.
Table 2 presents the prevalence of stroke and risk fac-
tors of atherosclerosis in the subgroups with single-vessel
and multi-vessel CAD in comparison to the control sub-
group without CAS. In the latter subgroup, the prevalence
of stroke was three times lower than in the multi-vessel
CAD subgroup.
In the COX proportional hazard regression model,
multi-vessel CAD was significantly associated with stroke
HR 1.8 (CI 1.03–3.43).
Discussion
Many clinical studies have revealed significant association
between stroke and CAD in patients with ischemic stroke.
All studies have used CT for coronary artery stenosis
evaluation, and stenosis of 50 % was considered as sig-
nificant. The disadvantage of these studies was a low
sensitivity and specificity for CT to detect coronary lesions
B50 %. None of the studies used coronary angiography
(the gold standard for coronary artery lesions assessment)
for coronary artery stenosis evaluation. Moreover, there
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Male 720 (60 %) 683 (60 %) 37 (73 %) NS
Age (years) 63.1 ± 9.2 63.0 ± 9.2 65.9 ± 8.6 0.02
Hypertension 913 (77 %) 870 (77 %) 43 (86 %) NS
Diabetes 248 (21 %) 237 (21 %) 11 (22 %) NS












55.1 ± 13.3 55.2 ± 13.4 52.3 ± 12.6 NS
Triglycerides
(mg/dL)
147.8 ± 98.2 147.7 ± 98.5 150.3 ± 93.0 NS
Medications




1,080 (91 %) 1,035 (91 %) 45 (90 %) NS




290 (24 %) 278 (24 %) 12 (24 %) NS
ACE-
inhibitors
868 (73 %) 828 (73 %) 40 (80 %) NS
ARB 50 (4 %) 48 (4 %) 2 (4 %) NS
Diuretics 222 (19 %) 210 (19 %) 12 (24 %) NS
Office SBP
(mmHg)
137.2 ± 19.9 137.1 ± 20.0 139.8 ± 17.7 NS
Office DBP
(mmHg)
78.1 ± 11.2 78.1 ± 11.2 78.3 ± 11.0 NS
Office PP
(mmHg)
59.15 ± 15.4 59.1 ± 15.6 61.2 ± 14.7 NS
Office HR
(bpm)
70.4 ± 12.1 70.4 ± 12.1 71.4 ± 12.1 NS
24-h systolic
BP (mmHg)
123.8 ± 13.6 123.7 ± 13.6 127.4 ± 14.1 NS
24-h diastolic
BP (mmHg)
71.3 ± 8.2 71.2 ± 8.2 72.8 ± 8.9 NS
24-h PP
(mmHg)
52.5 ± 11.2 52.4 ± 11.2 54.9 ± 11.0 NS
24-h HR
(bpm)
66.8 ± 9.7 66.7 ± 9.5 68.1 ± 12.1 NS
CAD 772 (60 %) 806 (71 %) 42 (84 %) \0.05
Single vessel
CAD
271(21 %) 282 (25 %) 11 (22 %) NS
Multi-vessel
CAD













Stroke deaths 10 (1 %) – 10 (20 %) –
All cause
deaths
144 (11 %) 123 (11 %) 20 (40 %) \0.01
ASA acetylsalicylic acid, lipid lowering drugs include statins and fi-
brates, ACE angiotensin converting enzyme, ARB angiotensin receptor
blocker, BP blood pressure, CAD coronary artery disease (at least one
C70 % coronary artery stenosis), CV cardiovascular
Table 2 Clinical characteristics and prevalence of CV events in the




CAD (n = 293)
Multi-vessel
CAD (n = 555)
Male 136 (41 %) 192 (65 %)* 392 (71 %)*
Age (years) 61.9 ± 8.6 62.9 ± 9.6 64.0 ± 9.2
Hypertension 258 (77 %) 222 (76 %) 433 (78 %)
Diabetes 52 (15 %) 63 (21 %) 133 (24 %)












58.7 ± 14.2 54.9 ± 14.1* 53.1 ± 11.9*
Triglycerides
(mg/dL)
137.5 ± 93.3 143.8 ± 86.6 156.0 ± 106.1
Medications




295 (88 %) 266 (91 %) 519 (93 %)




110 (33 %) 63 (21 %) 117 (21 %)
ACE-
inhibitors
215 (64 %) 218 (74 %)* 435 (78 %)*
ARB 23 (7 %) 15 (5 %) 12 (2 %)
Diuretics 58 (17 %) 51 (17 %) 113 (20 %)
Office SBP
(mmHg)
134.3 ± 18.4 139.5 ± 20.5 137.8 ± 20.3
Office DBP
(mmHg)
78.7 ± 10.4 78.6 ± 10.8 77.5 ± 11.8
Office PP
(mmHg)
55.5 ± 14.7 60.9 ± 16.1* 60.3 ± 15.5*
Office HR
(bpm)
71.5 ± 12.1 69.9 ± 12.2 70.1 ± 11.9
24-h systolic
BP (mmHg)
122.0 ± 13.1 124.3 ± 13.2 124.7 ± 14.1
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were no prospective trials with stroke risk assessment in
the follow-up period for patients with angiographically
established CAD. In some studies patients with supraven-
tricular arrhythmias (also not associated with CAD) were
included.
In the present prospective study, in symptomatic
patients with CAD assessed in coronary angiography, sig-
nificant coronary atherosclerosis (and especially multi-
vessel CAD) was significantly associated with the devel-
opment of stroke in the 7-year follow-up period. In spite of
comprehensive treatment of risk factors for atherosclerosis,
the risk of stroke in multi-vessel CAD was higher than in
patients with no CAS. Patients with multi-vessel CAD
were treated more extensively with acetylsalicylic acid,
beta blockers and ACE inhibitors than those without cor-
onary atherosclerosis.
The limitation of this study is that the grade of carotid
atheroma was not considered in all patients. Because the
purpose of this study was not assessment of the relationship
between CAD and carotid artery stenosis, only patients
with symptoms of carotid stenosis had Doppler ultraso-
nography performed. Another limitation is that stroke was
established mainly on the basis of computed tomography.
During the follow-up period, only some of the neurological
centers had MR devices.
In conclusion, significant CAD is associated with stroke
based on over 7 years of observation. Symptomatic
patients with multi-vessel CAD are considered to be at high
risk of stroke development.
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CAD (n = 293)
Multi-vessel
CAD (n = 555)
24-h diastolic
BP (mmHg)
71.1 ± 8.0 71.3 ± 7.6 71.4 ± 8.7
24-h PP
(mmHg)
50.9 ± 10.7 52.9 ± 11.3 53.3 ± 11.4*
24-h HR (bpm) 68.1 ± 9.7 65.8 ± 9.6* 66.5 ± 9.6




27 (8 %) 38 (13 %) 77 (14 %)
Stroke deaths 1 (0.3 %) 2 (0.7 %) 7 (1.3 %)
All cause
deaths
25 (7 %) 31 (11 %) 87 (16 %)*
ASA acetylsalicylic acid, lipid lowering drugs include statins and fi-
brates, ACE angiotensin converting enzyme, ARB angiotensin
receptor blocker, BP blood pressure, CAS coronary artery stenosis,
CAD coronary artery disease (at least one C70 % coronary artery
stenosis), CV cardiovascular
* p \ 0.01 vs. No CAS
 p \ 0.02 vs. No CAS
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